Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2000 | 06-2000 | 03-2000 | 12-1999 | 09-1999 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,121 | N/A | N/A | 14,560 | 17,050 |
| Marketable Securities | 14,052 | N/A | N/A | 7,380 | 4,800 |
| Receivables | 640 | N/A | N/A | 140 | 640 |
| Inventories | 92 | N/A | N/A | 80 | 80 |
| Other current assets | 0 | 0 | 0 | 160 | 210 |
| TOTAL | $31,091 | $N/A | $N/A | $22,320 | $22,780 |
| Non-Current Assets | |||||
| PPE Net | 4,155 | N/A | N/A | 13,740 | 13,730 |
| Other Non-Current Assets | 422 | 0 | 0 | 360 | 360 |
| TOTAL | $4,576 | $N/A | $N/A | $14,100 | $14,090 |
| Total Assets | $35,668 | $N/A | $N/A | $27,220 | $27,810 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 612 | 0 | 0 | 150 | 110 |
| Accrued Expenses | 849 | N/A | N/A | 540 | 580 |
| TOTAL | $5,384 | $N/A | $N/A | $760 | $760 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 3,924 | N/A | N/A | N/A | N/A |
| TOTAL | $15,978 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $21,362 | $N/A | $N/A | $760 | $760 |
| Shareholders' Equity | |||||
| Common Shares | 68 | N/A | N/A | 60 | 60 |
| Retained earnings | -28,111 | N/A | N/A | -18,270 | -16,840 |
| Other shareholders' equity | -1,919 | 0 | 0 | 460 | -370 |
| TOTAL | $14,306 | $N/A | $N/A | $26,450 | $27,050 |
| Total Liabilities And Equity | $35,668 | $0 | $0 | $27,210 | $27,810 |